CRLBF
Price
$0.80
Change
-$0.09 (-10.11%)
Updated
Nov 18 closing price
Capitalization
284.87M
119 days until earnings call
Intraday BUY SELL Signals
JUSHF
Price
$0.37
Change
-$0.01 (-2.63%)
Updated
Nov 18 closing price
Capitalization
72.79M
169 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRLBF vs JUSHF

Header iconCRLBF vs JUSHF Comparison
Open Charts CRLBF vs JUSHFBanner chart's image
Cresco Labs
Price$0.80
Change-$0.09 (-10.11%)
Volume$1.05M
Capitalization284.87M
Jushi Holdings
Price$0.37
Change-$0.01 (-2.63%)
Volume$309.04K
Capitalization72.79M
CRLBF vs JUSHF Comparison Chart in %
CRLBF
Daily Signal:
Gain/Loss:
JUSHF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRLBF vs. JUSHF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a Hold and JUSHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (CRLBF: $0.80 vs. JUSHF: $0.37)
Brand notoriety: CRLBF and JUSHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRLBF: 131% vs. JUSHF: 127%
Market capitalization -- CRLBF: $252.93M vs. JUSHF: $69.6M
CRLBF [@Pharmaceuticals: Generic] is valued at $252.93M. JUSHF’s [@Pharmaceuticals: Generic] market capitalization is $69.6M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whileJUSHF’s FA Score has 0 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • JUSHF’s FA Score: 0 green, 5 red.
According to our system of comparison, JUSHF is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRLBF’s TA Score shows that 4 TA indicator(s) are bullish while JUSHF’s TA Score has 4 bullish TA indicator(s).

  • CRLBF’s TA Score: 4 bullish, 6 bearish.
  • JUSHF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CRLBF and JUSHF are a bad buy in the short-term.

Price Growth

CRLBF (@Pharmaceuticals: Generic) experienced а -33.62% price change this week, while JUSHF (@Pharmaceuticals: Generic) price change was -43.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.77%. For the same industry, the average monthly price growth was -6.55%, and the average quarterly price growth was +28.28%.

Reported Earning Dates

CRLBF is expected to report earnings on Mar 18, 2026.

JUSHF is expected to report earnings on May 07, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.77% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($285M) has a higher market cap than JUSHF($72.8M). JUSHF YTD gains are higher at: 18.971 vs. CRLBF (-12.097). CRLBF has higher annual earnings (EBITDA): 136M vs. JUSHF (44.8M). CRLBF has more cash in the bank: 147M vs. JUSHF (23.2M). JUSHF has less debt than CRLBF: JUSHF (269M) vs CRLBF (631M). CRLBF has higher revenues than JUSHF: CRLBF (685M) vs JUSHF (256M).
CRLBFJUSHFCRLBF / JUSHF
Capitalization285M72.8M391%
EBITDA136M44.8M304%
Gain YTD-12.09718.971-64%
P/E RatioN/AN/A-
Revenue685M256M268%
Total Cash147M23.2M634%
Total Debt631M269M235%
FUNDAMENTALS RATINGS
CRLBF vs JUSHF: Fundamental Ratings
CRLBF
JUSHF
OUTLOOK RATING
1..100
6061
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
6465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JUSHF's Valuation (51) in the null industry is in the same range as CRLBF (81). This means that JUSHF’s stock grew similarly to CRLBF’s over the last 12 months.

JUSHF's Profit vs Risk Rating (100) in the null industry is in the same range as CRLBF (100). This means that JUSHF’s stock grew similarly to CRLBF’s over the last 12 months.

CRLBF's SMR Rating (91) in the null industry is in the same range as JUSHF (100). This means that CRLBF’s stock grew similarly to JUSHF’s over the last 12 months.

CRLBF's Price Growth Rating (64) in the null industry is in the same range as JUSHF (65). This means that CRLBF’s stock grew similarly to JUSHF’s over the last 12 months.

CRLBF's P/E Growth Rating (100) in the null industry is in the same range as JUSHF (100). This means that CRLBF’s stock grew similarly to JUSHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLBFJUSHF
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 10 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRLBF
Daily Signal:
Gain/Loss:
JUSHF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCNX45.94N/A
N/A
Rydex Transportation C
GEQZX66.21N/A
N/A
GuideStone Funds Equity Index Investor
TMFCX21.96N/A
N/A
Touchstone Mid Cap Value C
BSGPX13.36-0.10
-0.74%
Baillie Gifford Developed EAFE All Cap I
IRLAX82.49-1.15
-1.37%
Voya Russell Large Cap Growth Idx Port A

JUSHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JUSHF has been closely correlated with TCNNF. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if JUSHF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JUSHF
1D Price
Change %
JUSHF100%
-2.63%
TCNNF - JUSHF
74%
Closely correlated
N/A
CRLBF - JUSHF
74%
Closely correlated
-10.26%
CURLF - JUSHF
72%
Closely correlated
-2.45%
TSNDF - JUSHF
71%
Closely correlated
-9.29%
GTBIF - JUSHF
70%
Closely correlated
-2.69%
More